Resources from the same session
LBA23 - EPIK-P1: Retrospective chart review study of patients (pts) with <italic>PIK3CA</italic>-related Overgrowth Spectrum (PROS) who have received alpelisib (ALP) as part of a compassionate use programme
Presenter: Guillaume Canaud
Session: Proffered Paper session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
512O - Interim results from a phase II study of the ATR inhibitor ceralasertib in ARID1A-deficient and ARID1A-intact advanced solid tumor malignancies
Presenter: Rahul Aggarwal
Session: Proffered Paper session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
513O - A phase I/II multicenter, first-in-human study of DS-7300 (B7-H3 DXd-ADC) in patients (pts) with advanced solid tumors
Presenter: Melissa Johnson
Session: Proffered Paper session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
514O - An open-label, global, first-in-human study of SKB264 in patients with locally advanced or metastatic solid tumors
Presenter: Jordi Rodon
Session: Proffered Paper session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA23 and 512O
Presenter: Christophe Massard
Session: Proffered Paper session - Developmental therapeutics
Resources:
Slides
Webcast
Invited Discussant 513O and 514O
Presenter: Elena Garralda
Session: Proffered Paper session - Developmental therapeutics
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Elena Garralda
Session: Proffered Paper session - Developmental therapeutics
Resources:
Slides
Webcast